Acyclovir transport into human erythrocytes.
The mechanism of transport of the antiviral agent acyclovir (ACV) into human erythrocytes has been investigated. Initial velocities of ACV influx were determined with an "inhibitor-stop" assay that used papaverine to inhibit ACV influx rapidly and completely. ACV influx was nonconcentrative and appeared to be rate-saturable with a Km of 260 +/- 20 microM (n = 8). However, two lines of evidence indicate that ACV permeates the erythrocyte membrane by means other than the nucleoside transport system: 1) potent inhibitors (1.0 microM) of nucleoside transport (dipyridamole, 6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine, and dilazep) had little (less than 8% inhibition) or no effect upon the influx of 5.0 microM ACV; and 2) a 100-fold molar excess of several purine and pyrimidine nucleosides had no inhibitory effect upon the influx of 1.0 microM ACV. However, ACV transport was inhibited competitively by adenine (Ki = 9.5 microM), guanine (Ki = 25 microM), and hypoxanthine (Ki = 180 microM). Conversely, ACV was a competitive inhibitor (Ki = 240-280 microM) of the transport of adenine (Km = 13 microM), guanine (Km = 37 microM), and hypoxanthine (Km = 180 microM). Desciclovir and ganciclovir, two compounds related structurally to ACV, were also found to be competitive inhibitors of acyclovir influx (Ki = 1.7 and 1.5 mM, respectively). These results indicate that ACV enters human erythrocytes chiefly via the same nucleobase carrier that transports adenine, guanine, and hypoxanthine.
Mahony
W B
WB
Experimental Therapy Department, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709.
Domin
B A
BA
McConnell
R T
RT
Zimmerman
T P
TP
D000212:Acyclovir / Q000097:blood*; D000225:Adenine / Q000097:blood; D001692:Biological Transport / Q000187:drug effects; D002250:Carbon Radioisotopes; D004912:Erythrocytes / Q000378:metabolism*; D006147:Guanine / Q000097:blood; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000097:blood; D007065:Idoxuridine / Q000097:blood; D007457:Iodine Radioisotopes; D007700:Kinetics; D009705:Nucleosides / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D013395:Sucrose / Q000097:blood; D014316:Tritium
D002250:Carbon Radioisotopes; D007042:Hypoxanthines; D007457:Iodine Radioisotopes; D009705:Nucleosides; D011687:Purines; D011743:Pyrimidines; D014316:Tritium; D019271:Hypoxanthine; D013395:Sucrose; D006147:Guanine; D000225:Adenine; D007065:Idoxuridine; D000212:Acyclovir